GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lifeline SPAC I PLC (OHEL:LL1SPAC) » Definitions » Research & Development

Lifeline SPAC I (OHEL:LL1SPAC) Research & Development : €0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Lifeline SPAC I Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Lifeline SPAC I's Research & Development for the six months ended in Dec. 2023 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Lifeline SPAC I Research & Development Historical Data

The historical data trend for Lifeline SPAC I's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline SPAC I Research & Development Chart

Lifeline SPAC I Annual Data
Trend Dec21 Dec22 Dec23
Research & Development
- - -

Lifeline SPAC I Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Research & Development - - - -

Lifeline SPAC I Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifeline SPAC I  (OHEL:LL1SPAC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lifeline SPAC I Research & Development Related Terms

Thank you for viewing the detailed overview of Lifeline SPAC I's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifeline SPAC I (OHEL:LL1SPAC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lifeline SPAC I PLC (OHEL:LL1SPAC) » Definitions » Research & Development
Comparable Companies
BKK:MAJOR BKK:GRAMMY BKK:WORK BKK:YGG BKK:MONO BKK:RS BKK:ZAA PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA LSE:ADMR HCVI TRTL
Traded in Other Exchanges
N/A
Address
Pursimiehenkatu 26 C, Helsinki, FIN, FI-00150
Website
https://www.lifeline-spac1.com
Lifeline SPAC I PLC is a Nordic special-purpose acquisition company that aims to identify and acquire an unlisted technology-focused nordic company with high growth potential.

Lifeline SPAC I (OHEL:LL1SPAC) Headlines

No Headlines